Louis Yu Joins Albany Molecular Research
Executive Summary
Albany Molecular Research Inc. (AMRI) has appointed Louis Yu senior vice president of quality and compliance, a newly created position within the company. Yu joins AMRI, a global contract research and manufacturing organisation, from Perrigo Company PLC, where he was executive vice president, global quality and compliance. Prior to that, he was vice president of quality for CV Therapeutics (now a division of Gilead Sciences), and has also held a number of senior leadership roles at Forest Laboratories, Solvay Pharmaceuticals and Par Pharmaceutical.